IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment

Galluzzi, 2015, Immunological effects of conventional chemotherapy and targeted anticancer agents, Canc. Cell, 28, 690, 10.1016/j.ccell.2015.10.012 Apetoh, 2008, Immunogenicity of anthracyclines: moving towards more personalized medicine, Trends Mol. Med., 14, 141, 10.1016/j.molmed.2008.02.002 Vacchelli, 2015, Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1, Science, 350, 972, 10.1126/science.aad0779 Kroemer, 2013, Immunogenic cell death in cancer therapy, Annu. Rev. Immunol., 31, 51, 10.1146/annurev-immunol-032712-100008 Apetoh, 2007, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat. Med., 13, 1050, 10.1038/nm1622 Krysko, 2012, Immunogenic cell death and DAMPs in cancer therapy, Nat. Rev. Canc., 12, 860, 10.1038/nrc3380 Obeid, 2007, Calreticulin exposure dictates the immunogenicity of cancer cell death, Nat. Med., 13, 54, 10.1038/nm1523 Garg, 2012, A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death, EMBO J., 31, 1062, 10.1038/emboj.2011.497 Lu, 2018, Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the Ido-1 pathway, ACS Nano, 12, 11041, 10.1021/acsnano.8b05189 Molinaro, 2016, Biomimetic proteolipid vesicles for targeting inflamed tissues, Nat. Mater., 15, 1037, 10.1038/nmat4644 Kohli, 2014, Improving the distribution of Doxil(R) in the tumor matrix by depletion of tumor hyaluronan, J. Contr. Release, 191, 105, 10.1016/j.jconrel.2014.05.019 Zhao, 2018, Nanomaterial-based organelles protect normal cells against chemotherapy-induced cytotoxicity, Adv. Mater., 30 Lu, 2017, Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression, Nat. Commun., 8, 1811, 10.1038/s41467-017-01651-9 Wu, 2018, Radiation-sensitive dendrimer-based drug delivery system, Adv. Sci., 5, 1700339, 10.1002/advs.201700339 Liu, 2017, Safe and effective reversal of cancer multidrug resistance using sericin-coated mesoporous silica nanoparticles for lysosome-targeting delivery in mice, Small, 13, 1602567, 10.1002/smll.201602567 Munn, 2016, Ido in the tumor microenvironment: inflammation, counter-regulation, and tolerance, Trends Immunol., 37, 193, 10.1016/j.it.2016.01.002 Munn, 2007, Indoleamine 2,3-dioxygenase and tumor-induced tolerance, J. Clin. Invest., 117, 1147, 10.1172/JCI31178 Liu, 2017, Blockade of Ido-kynurenine-AhR metabolic circuitry abrogates IFN-gamma-induced immunologic dormancy of tumor-repopulating cells, Nat. Commun., 8, 15207, 10.1038/ncomms15207 Liu, 2018, Tumor-Repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation, Canc. Cell, 33, 480, 10.1016/j.ccell.2018.02.005 Spranger, 2013, Up-regulation of PD-L1, Ido, and T-regs in the melanoma tumor microenvironment is driven by CD8(+) T cells,, Sci. Transl. Med., 5, 10.1126/scitranslmed.3006504 Orabona, 2006, Toward the identification of a tolerogenic signature in Ido-competent dendritic cells, Blood, 107, 2846, 10.1182/blood-2005-10-4077 Jurgens, 2009, Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells, Blood, 114, 3235, 10.1182/blood-2008-12-195073 Quintana, 2010, An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis, Proc. Natl. Acad. Sci. U.S.A., 107, 20768, 10.1073/pnas.1009201107 Mezrich, 2010, An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells, J. Immunol., 185, 3190, 10.4049/jimmunol.0903670 Fallarino, 2006, The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells, J. Immunol., 176, 6752, 10.4049/jimmunol.176.11.6752 Rundhaug, 2003, Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor, Clin. Canc. Res., 9, 551 Kessenbrock, 2010, Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, 141, 52, 10.1016/j.cell.2010.03.015 Kis-Toth, 2013, Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001, Immunobiology, 218, 1361, 10.1016/j.imbio.2013.06.012 Li, 2018, Amphiphilic dendrimer engineered nanocarrier systems for co-delivery of siRNA and paclitaxel to matrix metalloproteinase-rich tumors for synergistic therapy, NPG Asia Mater., 10, 238, 10.1038/s41427-018-0027-4 Ping, 2011, Chitosan-graft-(PEI-beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery, Biomaterials, 32, 8328, 10.1016/j.biomaterials.2011.07.038 Zheng, 2016, Highly integrated nano-platform for breaking the barrier between chemotherapy and immunotherapy, Nano Lett., 16, 4341, 10.1021/acs.nanolett.6b01432 Son, 2002, A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells, J. Immunol. Methods, 262, 145, 10.1016/S0022-1759(02)00013-3 Liu, 2018, Supramolecular modular approach toward conveniently constructing and multifunctioning a pH/redox dual-responsive drug delivery nanoplatform for improved cancer chemotherapy, ACS Appl. Mater. Interfaces, 10, 26473, 10.1021/acsami.8b05232 Ye, 2016, Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors, ACS Nano, 10, 8956, 10.1021/acsnano.6b04989 Zhang, 2014, Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer- targeted drug delivery in vivo, Adv. Funct. Mater., 24, 2450, 10.1002/adfm.201302988 Mazzaferro, 2010, Polyethyleneimine-protein interactions and implications on protein stability, Int. J. Biol. Macromol., 47, 15, 10.1016/j.ijbiomac.2010.04.003 Such, 2015, Interfacing materials science and biology for drug carrier design, Adv. Mater., 27, 2278, 10.1002/adma.201405084 Hou, 2007, Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses, Canc. Res., 67, 792, 10.1158/0008-5472.CAN-06-2925 Casares, 2005, Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death, J. Exp. Med., 202, 1691, 10.1084/jem.20050915 Tillman, 2000, Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model, Canc. Res., 60, 5456 Reis e Sousa, 2006, Dendritic cells in a mature age, Nat. Rev. Immunol., 6, 476, 10.1038/nri1845 Tze, 2011, CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation, J. Exp. Med., 208, 149, 10.1084/jem.20092203 Chung, 2009, Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells, Blood, 114, 555, 10.1182/blood-2008-11-191197 Nguyen, 2010, Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism, Proc. Natl. Acad. Sci. U.S.A., 107, 19961, 10.1073/pnas.1014465107 Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells, Nat. Immunol., 4, 1206, 10.1038/ni1003 Nair, 2011, CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment, J. Immunol., 187, 1243, 10.4049/jimmunol.1100016 Golden, 2015, Radiotherapy and immunogenic cell death, Semin. Radiat. Oncol., 25, 11, 10.1016/j.semradonc.2014.07.005 Rodriguez-Ruiz, 2016, Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming, Canc. Res., 76, 5994, 10.1158/0008-5472.CAN-16-0549 Ngwa, 2018, Using immunotherapy to boost the abscopal effect, Nat. Rev. Canc., 18, 313, 10.1038/nrc.2018.6 Lu, 2016, Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy, J. Am. Chem. Soc., 138, 12502, 10.1021/jacs.6b06663 Tsukumo, 2018, Regulation of CD8(+) T cells and antitumor immunity by notch signaling, Front. Immunol., 9, 101, 10.3389/fimmu.2018.00101 Maldonado, 2010, How tolerogenic dendritic cells induce regulatory T cells, Adv. Immunol., 108, 111, 10.1016/B978-0-12-380995-7.00004-5 Mempel, 2004, T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases, Nature, 427, 154, 10.1038/nature02238 Fransen, 2013, Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment, Int. J. Canc., 132, 1971, 10.1002/ijc.27755 Sideras, 2018, Prognostic value of intra-tumoral CD8(+)/FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis, J. Surg. Oncol., 118, 68, 10.1002/jso.25091 Quezada, 2006, CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells, J. Clin. Invest., 116, 1935, 10.1172/JCI27745